Area of research
Pharmacology · Statistics and Probability
Research interest
Research interests include Medicine, Erythropoietin, Encephalopathy, Gestational age, Hypoxic Ischemic Encephalopathy, and Pediatrics.
Process guide for inferential studies using healthcare data from routine clinical practice to evaluate causal effects of drugs (PRINCIPLED): considerations from the FDA Sentinel Innovation Center
Predictors of Death or Severe Impairment in Neonates With Hypoxic-Ischemic Encephalopathy
Genetic and Congenital Anomalies in Infants With Hypoxic-Ischemic Encephalopathy
How well does neonatal neuroimaging correlate with neurodevelopmental outcomes in infants with hypoxic-ischemic encephalopathy?
Association of High-Dose Erythropoietin With Circulating Biomarkers and Neurodevelopmental Outcomes Among Neonates With Hypoxic Ischemic Encephalopathy
Frailty and Risk of Serious Infections in Patients With Rheumatoid Arthritis Treated With Biologic or <scp>Targeted‐Synthetic Disease‐Modifying</scp> Antirheumatic Drugs
Safety of High Dose Erythropoietin Used with Therapeutic Hypothermia as Treatment for Newborn Hypoxic-Ischemic Encephalopathy: Secondary Analysis of the HEAL Randomized Controlled Trial
Evolution of the Sarnat exam and association with 2-year outcomes in infants with moderate or severe hypoxic-ischaemic encephalopathy: a secondary analysis of the HEAL Trial
Trial of Erythropoietin for Hypoxic–Ischemic Encephalopathy in Newborns
Prevalence and Risk Factors for Kidney Disease and Elevated BP in 2-Year-Old Children Born Extremely Premature
Risk of seizures in neonates with hypoxic-ischemic encephalopathy receiving hypothermia plus erythropoietin or placebo
Urine acute kidney injury biomarkers in extremely low gestational age neonates: a nested case control study of 21 candidate urine biomarkers
Stepped Collaborative Care Targeting Posttraumatic Stress Disorder Symptoms and Comorbidity for US Trauma Care Systems
Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
The Impact of Erythropoietin on Short- and Long-Term Kidney-Related Outcomes in Neonates of Extremely Low Gestational Age. Results of a Multicenter, Double-Blind, Placebo-Controlled Randomized Clinical Trial
Severe Acute Kidney Injury and Mortality in Extremely Low Gestational Age Neonates
Enteral Iron Supplementation in Infants Born Extremely Preterm and its Positive Correlation with Neurodevelopment; Post Hoc Analysis of the Preterm Erythropoietin Neuroprotection Trial Randomized Controlled Trial
A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants
Prevalence of acute kidney injury (AKI) in extremely low gestational age neonates (ELGAN)
Effect of High-Dose Erythropoietin on Blood Transfusions in Extremely Low Gestational Age Neonates
Indicators of retention in remote digital health studies: a cross-study evaluation of 100,000 participants
Comparative Efficacy of Therapies for Treatment of Depression for Patients Undergoing Maintenance Hemodialysis
Religiosity, Social Support, and Ethnic Identity: Exploring “Resilience Resources” for African-American Women Experiencing HIV-Related Stigma
Patterns of alcohol use and associated characteristics and HIV-related outcomes among a sample of African-American women living with HIV
High-Dose Erythropoietin for Asphyxia and Encephalopathy (HEAL): A Randomized Controlled Trial – Background, Aims, and Study Protocol
HIV-Related Stigma and Viral Suppression Among African-American Women: Exploring the Mediating Roles of Depression and ART Nonadherence
Using Natural Language Processing of Free-Text Radiology Reports to Identify Type 1 Modic Endplate Changes
High-Dose Erythropoietin and Hypothermia for Hypoxic-Ischemic Encephalopathy: A Phase II Trial
Predictors of treatment with dialysis modalities in observational studies for comparative effectiveness research
Rationale and design of A Trial of Sertraline vs. Cognitive Behavioral Therapy for End-stage Renal Disease Patients with Depression (ASCEND)